Search Results - "GRUTSCH, J"

Circadian function in patients with advanced non-small-cell lung cancer by LEVIN, R. D, DAEHLER, M. A, DESAI, B, SHARMA, P, WALLAM, M, DELIOUKINA, M, BALL, P, BRYANT, M, ASHFORD, M, COPELAND, D, OHMORI, M, WOOD, P. A, GRUTSCH, J. F, HRUSHESKY, W. J. M, QUITON, J, L I S, C. G, PETERSON, C, GUPTA, D, WATSON, K, LAYER, D, HUFF-ADAMS, S

“…This study aimed to evaluate whether patients with advanced non-small-cell lung cancer experience disrupted rest-activity daily rhythms, poor sleep quality,…”
Get full text

Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer by Gupta, D, Lammersfeld, C.A, Vashi, P.G, Burrows, J, Lis, C.G, Grutsch, J.F

“…Objective: To evaluate the prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer and create statistically distinct…”
Get full text

Synthesis, Pharmacological Characterization, and Molecular Modeling of Heterobicyclic Amino Acids Related to (+)-2-Aminobicyclo[3.1.0]hexane- 2,6-dicarboxylic Acid (LY354740):  Identification of Two New Potent, Selective, and Systemically Active Agonists for Group II Metabotropic Glutamate Receptors by Monn, James A, Valli, Matthew J, Massey, Steven M, Hansen, Marvin M, Kress, Thomas J, Wepsiec, James P, Harkness, Allen R, Grutsch, John L, Wright, Rebecca A, Johnson, Bryan G, Andis, Sherri L, Kingston, Ann, Tomlinson, Rosemarie, Lewis, Richard, Griffey, Kelly R, Tizzano, Joseph P, Schoepp, Darryle D

“…As part of our ongoing research program aimed at the identification of highly potent, selective, and systemically active agonists for group II metabotropic…”
Get full text

Recurrence of vestibular (acoustic) schwannomas in surgical patients where preservation of facial and cochlear nerve is the priority by CERULLO, J. GRUTSCH, R. OSTERDOCK, L.

“…The risk of tumour recurrence was measured in a series of surgically treated vestibular (acoustic) schwannoma patients where preservation of facial and…”
Get full text

The Relationship Between Cancer-Related Fatigue and Patient Satisfaction with Quality of Life in Cancer by Gupta, Digant, MD, MPH, Lis, Christopher G., MPH, Grutsch, James F., PhD

“…Abstract Fatigue affects a majority of patients undergoing cancer-related therapies. We conducted a study of 954 adult cancer patients presenting for treatment…”
Get full text

Association of meningioma with reproductive factors by Lee, Eunsuk, Grutsch, James, Persky, Victoria, Glick, Roberta, Mendes, Juliana, Davis, Faith

“…Meningiomas occur more commonly in females. The coincidence between meningioma and breast cancer and case reports of tumor growth during pregnancy support a…”
Get full text

Can health-related quality-of-life outcome measures predict patient satisfaction with service quality in oncology? by Lis, C. G., Rodeghier, M., Grutsch, J. F., Gupta, D.

“…Abstract only…”
Get full text

The relationship between service quality measures and overall patient satisfaction in oncology by Grutsch, J. F., Lis, C. G., Rodeghier, M., Gupta, D.

“…Abstract only…”
Get full text

Relationship between lack of patient compliance with adjuvant therapy guidelines and recurrence in early breast cancer by Citrin, D. L., Neelam, R., Grutsch, J. F., Mortensen, S. J.

“…Abstract only 215 Background: Modern treatment (Tx) of early stage breast cancer (BC) often requires a combination of surgery, radiation and adjuvant drugs…”
Get full text

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End results (SEER) data, 1973-1991 by DAVIS, F. G, FREELS, S, GRUTSCH, J, BARLAS, S, BREM, S

“…The authors present population-based survival rate estimates for patients with malignant primary brain tumors based on an analysis of 18 years of data obtained…”
Get full text

The effect of 3 months of integrative cancer treatment on quality of life for patients with lung cancer by Staren, E. D., Gupta, D., Grutsch, J. F., Braun, D. P.

“…Abstract only…”
Get full text

Can changes in health-related quality-of-life scores predict survival in colorectal cancer? by Braun, D. P., Gupta, D., Grutsch, J. F., Staren, E. D.

“…Abstract only…”
Get full text

The relationship between service quality measures and patient willingness to recommend at a national oncology provider network: The Cancer Treatment Centers of America experience by Gupta, D., Rodeghier, M., Grutsch, J. F., Roberts, A., Lis, C. G.

“…Abstract only…”
Get full text

The prognostic role of quality-of-life assessment in lung cancer by Braun, D. P., Gupta, D., Grutsch, J. F., Staren, E. D.

“…Abstract only…”
Get full text

Biphasic responses, quantal signals and cellular behaviour by Robertson, A D, Grutsch, Jr, J F

“…It is commonplace to think of thresholds in biological systems. Biphasic responses, with both thresholds and upper limits, or lintels, are also surprisingly…”
Get more information

Signs and mechanisms of chlordane intoxication by Grutsch, J F, Khasawinah, A

“…Chlordane is a cyclopentadiene-derived insecticide that exerts its toxic action on the nervous system. In experimental animals the characteristic signs of…”
Get more information

Chlordane: 24-month tumorigenicity and chronic toxicity test in mice by Khasawinah, A M, Grutsch, J F

“…Four groups of 80 ICR SPF mice of each sex were fed 0-12.5 ppm technical chlordane for 104 weeks. Male and female mice were examined for hematological,…”
Get more information

Serum 25-hydroxy vitamin D and nutritional status: Implications for vitamin D assessment and dietary supplementation in oncology by Trukova, K., Gupta, D., Vashi, P. G., Adams, A., Lambert, G. M., Grutsch, J. F., Lammersfeld, C. A.

“…Abstract only 9638 Background: There is emerging evidence in the literature to suggest a protective role of vitamin D in cancer survival. Vitamin D status is…”
Get full text

Symptom control in cancer using an integrative treatment approach: The Cancer Treatment Centers of America experience by Lis, C. G., Birdsall, T. C., Grutsch, J. F., Gupta, D.

“…Abstract only…”
Get full text

Chlordane: thirty-month tumorigenicity and chronic toxicity test in rats by Khasawinah, A M, Grutsch, J F

“…Groups of 80 Fischer 344 specific-pathogen-free rats of each sex were fed 0, 1, 5, and 25 ppm chlordane for 130 weeks. The rats were examined for…”
Get more information